Construction of a Screening and Precision Intervention System for Adolescent Idiopathic Scoliosis Based on the DIERS Spinal Moiré System
Condition(s) studied
Study summary
Taking the DIERS Spinal Moiré System as the primary tool, this study intends to establish an early warning model for adolescent scoliosis based on the system, verify the quantitative relationship between different body postures, three-dimensional pelvic parameters (inclination, rotation angle, torsion angle) and Cobb angle progression, analyze the pelvic compensation characteristics of different Lenke classifications, establish a biomechanical prediction model, develop a dynamic risk assessment algorithm suitable for campus screening, formulate personalized rehabilitation programs under the guidance of DIERS parameters, evaluate the inhibitory effect of biofeedback training on scoliosis progression, and form a standardized "screening-diagnosis-intervention-management" process.
This project will develop and promote a screening and precision intervention system for adolescent scoliosis based on the DIERS Spinal Moiré System. The research outcomes of this project will assist the clinical diagnosis and treatment of adolescent idiopathic scoliosis, and propose a precision diagnosis and treatment strategy led by a quantitative data platform. The research findings of the project will be mainly submitted in the form of papers, with the plan to publish 1-2 papers indexed in SCI.
Eligibility
Primary outcome measure(s)
- Cobb angle — through study completion, an average of 2 year
Compare the Cobb angles measured by the DIERS 4D System in two positions (arms hanging naturally and elbows bent with hands on shoulders) with those measured by X-ray, respectively.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Nantong First People's Hospital | Nantong | Jiangsu |
More Jiawei Jiang trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07899294 on ClinicalTrials.gov ↗ ← All trials in China